Abstract

ABSTRACT Mucin 1 (MUC1), a transmembrane glycoprotein, has shown to be as the possible prognostic marker to predict the risk of aggressive head and neck squamous cell carcinoma (HNSCC). In the present study, we investigated the effect of MUC1 in HNSCC cells and the response to X-ray irradiation (IR). Here, we examined the impact of MUC1 overexpression or downexpression on clonogenic survival and apoptosis in response to X-ray irradiation (IR). Radioresistance and radiosensitivity were also observed in HNSCC cells that are MUC1 overexpression and MUC1 downexpression. This enhanced resistance to IR in MUC1-overexpressing cells is primarily due to increased the number of radiation-induced γH2AX/53BP1-positive foci and DNA double-strand break (DSB) repair kinetics. MUC1 overexpression repaired more than 90% of DSBs after 2 Gy radiation by 24 h compared to the empty vector overexpressing cells with less than 50% of DSB repair. However, MUC1 downexpression repaired less than 20% of DSBs compared to the empty vector-overexpresing cells. MUC1 overexpression inhibited proapoptotic protein expression, such as caspase-3, caspase-8, and caspase-9, and induced antiapoptotic protein Bcl-2, followed by resistance to IR-induced apoptosis. Our results showed that targeting MUC1 may be as a promising strategy to counteract radiation resistance of HNSCC cells.

Highlights

  • Head and neck squamous cell carcinoma (HNSCC) originates from the mucosa of the oral cavity, pharynx, and larynx, which is characterized by poor survival rates in advanced stages and fails current treatments

  • We demonstrate that targeting Mucin 1 (MUC1) inhibited cell growth and induced apoptosis and renders head and neck squamous cell carcinoma (HNSCC) cells sensitive to IR treatment in vitro

  • MUC1 expression was monitored on transcript and protein levels in well-established HNSCC cell line Hep2, TU-212, TU686, TU177, and AMC-HN -8 cells

Read more

Summary

Introduction

Head and neck squamous cell carcinoma (HNSCC) originates from the mucosa of the oral cavity, pharynx, and larynx, which is characterized by poor survival rates in advanced stages and fails current treatments. The combined therapy in HNSCC patients with unresectable advanced disease only achieved less than

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.